Elequin Capital’s Oak Street Health, Inc. OSH Stock Holding History

Elequin Capital’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-146	Closed	-$4K	–	834
2022 Q3	$4K	Sell	146 -216	-60%	-$5.71K	﹤0.01%	435
2022 Q2	$6K	Buy	362 +61	+20%	+$1.19K	﹤0.01%	285
2022 Q1	$8K	Buy	+301	New	+$6.34K	﹤0.01%	190

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Elequin Capital's OSH Position: Q4 2022 in Review

Elequin Capital sold out of Oak Street Health, Inc. (OSH) in Q4 2022, closing a stake of 146 shares — an estimated $4K sold.

Elequin Capital first reported a position in OSH in Q1 2022 and held it in 3 quarters. The position peaked at $8K in Q1 2022. 219 funds tracked by Wall St. Rank hold OSH as of Q4 2022.

Elequin Capital reported no remaining Oak Street Health, Inc. position as of Q4 2022 after selling out during the quarter.
Elequin Capital sold 146 Oak Street Health, Inc. shares in Q4 2022, an estimated $4K.
Elequin Capital first reported a position in Oak Street Health, Inc. in Q1 2022 and held it in 3 quarters.
Elequin Capital's Oak Street Health, Inc. position peaked at $8K in Q1 2022.
219 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q4 2022.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.